JCO Oncology Advances
Wolters Kluwer Health - Lippincott Williams Wilkins
About the journal
JCO Oncology Advances is an open-access journal published by Wolters Kluwer Health - Lippincott Williams Wilkins in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,800 USD. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wolters Kluwer Health - Lippincott Williams Wilkins
- ISSN
- 2994-9750
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,800 USD
- Articles in DOAJ
- 0
- Declared review time
- 18 weeks
- Declared peer-review model
- peer_review
- Official website
- https://ascopubs.org/journal/oa
Index listings
- DOAJ · 2025-09-08
- Indexing
- DOAJ
- APC
- 3,800 USD
- Declared review time (DOAJ)
- 18 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
18weeks
Works in OpenAlex
170
Last recorded publication year
2026
h-index
7
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2025-09-08
- Added to DOAJ
- 2025-09-08
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 97%
- Enrolled in Crossref Similarity Check
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JCO oncology advances
- Source type
- journal
- NLM unique ID (PubMed)
- 9918956761606676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
Show all subjects (50)
- Cancer Genomics and Diagnostics
- Ethics in Clinical Research
- Ethics in Clinical Research
- Cancer Genomics and Diagnostics
- Cancer survivorship and care
- Head and Neck Cancer Studies
- Advanced Breast Cancer Therapies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Lung Cancer Treatments and Mutations
- Global Cancer Incidence and Screening
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Sarcoma Diagnosis and Treatment
- Cancer survivorship and care
- Lung Cancer Treatments and Mutations
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- Advanced Breast Cancer Therapies
- Lung Cancer Research Studies
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Esophageal Cancer Research and Treatment
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Head and Neck Cancer Studies
- Cancer Research and Treatments
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Esophageal Cancer Research and Treatment
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Genetic factors in colorectal cancer
- Endometrial and Cervical Cancer Treatments
- Immunotherapy and Immune Responses
- Genetic factors in colorectal cancer
- Endometrial and Cervical Cancer Treatments
- Ovarian cancer diagnosis and treatment
- Glioma Diagnosis and Treatment
Keywords (DOAJ)
- oncology
- global health
- cancer research
- clinical medicine
- cancer
- public health
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ